Surprisingly, TNF-α expression increases from hyperplasia to carcinoma, and also during TNM stages in GBC tissues [49], suggesting that TNF-α could participate in carcinogenic processes and may be a progression marker in GBC patients. The gene discussed is TNF; the disease is carcinoma.